Navigation Links
Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
Date:7/23/2008

SEATTLE, July 23 /PRNewswire/ -- Sound Pharmaceuticals (SPI) has filed an Investigational New Drug Application with the FDA for the clinical testing of a proprietary formulation of ebselen for the prevention of chemotherapy induced hearing loss or ototoxicity. The oral capsule containing ebselen, SPI-3005, will be tested in advanced stage lung cancer and head and neck cancer patients receiving platinum based chemotherapy. This marks the second development program for SPI to enter clinical testing for a hearing loss indication. Last year, SPI-1005, an oral capsule containing ebselen entered Phase II testing with the US Navy for the prevention and treatment of noise induced hearing loss.

Currently there are no FDA approved drugs for the prevention and treatment of drug induced hearing loss or ototoxicity. SPI hopes to address this unmet medical need with its first in class first in indication drug. Several different research groups have shown that chemotherapy treatment reduces glutathione peroxidase (GPx) activity in the mammalian inner ear resulting in hearing loss, tinnitus, vertigo and dizziness. GPx is the dominant catalytic antioxidant enzyme within the inner ear, and a loss of its activity results in irreparable damage to hair cells, neurons and non-sensory tissues that are critical for hearing and balance. "A dose limiting side effect of platinum based chemotherapies are their devastating ototoxicity and neurotoxicity, and SPI-3005 is designed to attenuate these side effects without inhibiting the therapeutic efficacy of platinum or taxane based chemotherapies," said VP Eric Lynch, PhD.

"Otoprotectants such as SPI-3005 have the potential to reduce and/or alleviate chemotherapy-induced ototoxicity, and clinical studies should be pursued," said Stephen Fausti, PhD, and Director of the National Center for Rehabilitative Auditory Research (NCRAR) at the Portland VA, Professor of Otolaryngology and Neurology at Oregon Health Sciences University
'/>"/>

SOURCE Sound Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
2. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
3. Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
4. Applisonix Announces Breakthrough in Ultrasound Technology for Hair Removal - Average Hair Reduction of 38% Following Initial Treatment
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014   LabStyle Innovations ... Solution, today announced the appointment of Professor ... of its Board of Directors. Prof. ... business experience to LabStyle as an entrepreneur, venture ... and corporate governance expert. He currently serves on ...
(Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
(Date:1/15/2014)... ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" research ... http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging of ... orthopedic instrument industry has seen rapid development ... 3.28 billion yuan in 2006 to 9.85 billion yuan ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader ... Tech International (PTI), a joint venture of its subsidiary ... sales agreement with Cure Hands, a company of international ... agreement, Pharma Tech International, the exclusive distributor of CellerateRX® ...
... May 16, 2011 UBM Canon,s medical device publishing ... for the remainder of 2011. (Logo: ... an exciting list of comprehensive content topics that encompass ... outsourcing," stated Rich Nass, Director of Content for the ...
Cached Medicine Technology:International Sales Agreement Signed by WNDM Subsidiary; $500K First-Year Sales Commitment 2International Sales Agreement Signed by WNDM Subsidiary; $500K First-Year Sales Commitment 3International Sales Agreement Signed by WNDM Subsidiary; $500K First-Year Sales Commitment 4UBM Canon Medical Device Content Team Announces Upcoming Virtual Event Content Topics 2UBM Canon Medical Device Content Team Announces Upcoming Virtual Event Content Topics 3
(Date:7/11/2014)... Obese and overweight firefighters are not receiving weight ... to new research from The University of Texas ... guidelines state that health care professionals (HCPs) should ... healthy weight. Firefighters have high rates of obesity, ... line-of-duty deaths in firefighters. This study assessed the ...
(Date:7/11/2014)... NY (PRWEB) July 11, 2014 The ... the five years to 2014 on the heels of ... 2010 prompted farmers to dedicate a larger share of ... production. More specifically, the regulations required the mixing of ... expanding biofuel production in the United States created a ...
(Date:7/11/2014)... HealthDay Reporter THURSDAY, July 10, ... from the worldwide scourge of dengue fever was somewhat successful ... only prevented dengue fever in 56 percent of the 10,000 ... protected more than 88 percent of them from severe disease. ... and sometimes death. "This vaccine has already proven to ...
(Date:7/11/2014)... July 11, 2014 Ticket Down is a reliable ... in Mountain View, CA. Over the years Luke Bryan has ... Not only does he do well at award shows, but each ... the most anticipated tours of the genre and this summer is ... artists can compare to the popularity and success that is currently ...
(Date:7/11/2014)... Riverside Health System became the first provider of ... late 2012 and now, in partnership with Williamsburg Landing, will ... Williamsburg and Newport News region. , Also known as life ... independent older adults who wish to remain in their homes ... continuing care services as well as control over the cost ...
Breaking Medicine News(10 mins):Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4
... New Survey Indicates that a Patient,s or Loved One,s Hearing ... to Inefficiency and ... Hearing loss among those,who require the assistance of a caregiver ... providing care, according to a new survey,released by Songbird Hearing, ...
... Winners Can Receive Up to $15,000 Each to Donate to Nonprofit of Their ... ... The deadline to submit,nominations for this year,s Welcome Back Awards, a national awards ... are now due by Monday, December 15, 2008., The Welcome Back Awards ...
... Calif., Nov. 12 Forterus,Inc. (OTC Bulletin Board: FTER) ... back up to $20,000 in stock in open market,transactions., ... is severely,undervalued, and does not reflect the financial success ... past two months," said,Paul Howarth, CEO of Forterus., ...
... Study Links Quercetin To Reduced Risk for Respiratory Infection, ... for a natural,way to stay well this cold and ... of today,s hottest "Super Fruits." In conjunction with,the typical ... known for its natural anti-viral activity and found in ...
... Inc.,(Nasdaq: ENMD ), a clinical-stage pharmaceutical company ... diseases,reported corporate and clinical program updates for the ... The updates were given during,a podium presentation by ... web,cast at the Rodman & Renshaw 10th Annual ...
... of the Place They Live , ... Alpharetta, Ga. (Vocus) November 12, ... headquarters on October 17, 2008. The building houses the six operating ... Associates had significant input into the design of the building from ...
Cached Medicine News:Health News:Hearing Loss Presents a Significant Challenge for Rising Number of Caregivers 2Health News:Hearing Loss Presents a Significant Challenge for Rising Number of Caregivers 3Health News:Hearing Loss Presents a Significant Challenge for Rising Number of Caregivers 4Health News:Deadline Extended to Submit Nominations for Depression Awards Program 2Health News:Deadline Extended to Submit Nominations for Depression Awards Program 3Health News:Forterus Inc. Announces Stock Buyback 2Health News:New Research Shows Specific Antioxidant, Found in Cherries, May Boost the Body's Defenses Against the Flu 2Health News:EntreMed Reports Clinical Program Progress and Company Update 2Health News:EntreMed Reports Clinical Program Progress and Company Update 3Health News:EntreMed Reports Clinical Program Progress and Company Update 4Health News:EntreMed Reports Clinical Program Progress and Company Update 5Health News:Jackson Healthcare Dedicates New Corporate Headquarters 2Health News:Jackson Healthcare Dedicates New Corporate Headquarters 3
... The Xact stent is self-expanding and has ... yet highly flexible mesh intended to help restore ... a smooth inner vessel surface, and potentially reduce ... diseased vessel when it is treated, which can ...
... Super Premium ALPHA 10 System offers ... in an intuitive and ergonomically designed ... ideal system for Perinatology/Maternal & Fetal ... Applications, Breast Imaging, and General Imaging ...
... (hGH; somatotropin) is a 22 kD, 191 amino ... of the anterior pituitary. The hGH gene contains ... five members of a gene family. The hGH ... of hGH released into the cell culture supernatant ...
... is the sulfate ester of DHEA, derived ... of DHEA in adrenal and extradrenal tissues. ... by the adrenal cortex, and is a ... possesses relatively weak androgenic activity, which for ...
Medicine Products: